<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">27655410</PMID>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-8722</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Sep</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of hematology &amp; oncology</Title>
                <ISOAbbreviation>J Hematol Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>91</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">NT1014 is a novel biguanide and AMPK activator with a high affinity for the organic cation-specific transporters, OCT1 and OCT3. We sought to determine the anti-tumorigenic effects of NT1014 in human ovarian cancer cell lines as well as in a genetically engineered mouse model of high-grade serous ovarian cancer.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The effects of NT1014 and metformin on cell proliferation were assessed by MTT assay using the human ovarian cancer cell lines, SKOV3 and IGROV1, as well as in primary cultures. In addition, the impact of NT1014 on cell cycle progression, apoptosis, cellular stress, adhesion, invasion, glycolysis, and AMPK activation/mTOR pathway inhibition was also explored. The effects of NT1014 treatment in vivo was evaluated using the K18 - gT121<sup>+/-</sup>; p53<sup>fl/fl</sup>; Brca1<sup>fl/fl</sup> (KpB) mouse model of high-grade serous ovarian cancer.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">NT1014 significantly inhibited cell proliferation in both ovarian cancer cell lines as well as in primary cultures. In addition, NT1014 activated AMPK, inhibited downstream targets of the mTOR pathway, induced G1 cell cycle arrest/apoptosis/cellular stress, altered glycolysis, and reduced invasion/adhesion. Similar to its anti-tumorigenic effects in vitro, NT1014 decreased ovarian cancer growth in the KpB mouse model of ovarian cancer. NT1014 appeared to be more potent than metformin in both our in vitro and in vivo studies.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NT1014 inhibited ovarian cancer cell growth in vitro and in vivo, with greater efficacy than the traditional biguanide, metformin. These results support further development of NT1014 as a useful therapeutic approach for the treatment of ovarian cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Lu</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Jianjun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Oncology, Shandong Cancer Hospital and Institute, Jinan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jackson</LastName>
                    <ForeName>Amanda L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clark</LastName>
                    <ForeName>Leslie N</ForeName>
                    <Initials>LN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kilgore</LastName>
                    <ForeName>Joshua</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Livingston</LastName>
                    <ForeName>Nick</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>NovaTarg Therapeutics, Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batchelor</LastName>
                    <ForeName>Kenneth</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>NovaTarg Therapeutics, Research Triangle Park, Durham, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Yajie</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gilliam</LastName>
                    <ForeName>Timothy P</ForeName>
                    <Initials>TP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gehrig</LastName>
                    <ForeName>Paola A</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sheng</LastName>
                    <ForeName>Xiugui</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Jinan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Chunxiao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA. czhou@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. czhou@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bae-Jump</LastName>
                    <ForeName>Victoria L</ForeName>
                    <Initials>VL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, USA. victoria_baejump@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. victoria_baejump@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>K23 CA143154</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 CA016086</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Hematol Oncol</MedlineTA>
            <NlmUniqueID>101468937</NlmUniqueID>
            <ISSNLinking>1756-8722</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AMPK</Keyword>
            <Keyword MajorTopicYN="N">Biguanide</Keyword>
            <Keyword MajorTopicYN="N">NT1014</Keyword>
            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
            <Keyword MajorTopicYN="N">Small compound</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27655410</ArticleId>
            <ArticleId IdType="doi">10.1186/s13045-016-0325-7</ArticleId>
            <ArticleId IdType="pii">10.1186/s13045-016-0325-7</ArticleId>
            <ArticleId IdType="pmc">PMC5031332</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25220842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2016 Jun;99(6):633-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26659468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynecol Cancer. 2013 Nov;23(9):1544-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24172091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Apr 24;348(17):1625-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12711737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Prev Res (Phila). 2012 Jul;5(7):901-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22609763</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2015 Nov 10;6(35):37281-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26484566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2012 Aug 15;72(16):4141-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22617326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Renal Physiol. 2008 Jul;295(1):F165-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18508876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenet Genomics. 2012 Nov;22(11):820-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22722338</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Obes Metab. 2014 Aug;16(8):707-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24460896</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Lett. 2015 Sep;10(3):1527-1532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26622703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obstet Gynecol Surv. 2014 Aug;69(8):477-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25144611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2008 Feb;39(2):275-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18045648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2011 Jun 1;121(3):492-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21388661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Targets. 2012 Dec;13(14):1876-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23140331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 2010 Mar;176(3):1169-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20110413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 May 21;9(5):e97781</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24849329</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncol Rep. 2012 Jun;27(6):1873-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22469973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Pharmacol. 2015 Dec;88(6):1062-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26424816</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacokinet. 2011 Feb;50(2):81-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21241070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2014 Dec;135(3):614-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25455733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2011 Nov 4;414(4):694-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21986525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tumour Biol. 2016 Apr;37(4):5337-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26561471</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Endocrinol. 2014 Aug;10(8):455-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24935119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(7):e22163</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21779389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 May 23;9(5):e98207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24858012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Aug 23;8(8):e74420</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24009772</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2014 Sep 1;74(17 ):4783-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24994714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2015 Sep 15;6(27):23548-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26172303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9983-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24961373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1987 Dec 1;60(11):2823-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3677015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2000;5(1):26-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10706647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2013 Aug 9;336(1):114-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23612073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ovarian Res. 2014 Apr 22;7:41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24834130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2012 Dec 1;72(23):6257-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23041548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2015 Jan 30;6:6137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25635515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Relat Cancer. 2013 Mar 22;20(2):251-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23404857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2015 Jul;34(28):3627-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25241895</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2009 May 22;324(5930):1029-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19460998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10574-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25002509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2015 Sep 15;121(18):3203-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26096019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2015 Sep 1;75(17):3529-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26330165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Res. 2017 Jan;42(1):294-305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26433380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharmacol Ther. 2013 Nov;94(5):585-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23863876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26742998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2011 Apr;121(1):106-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21236474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2014 Apr;133(1):90-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24680597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tumour Biol. 2015 Aug;36(8):6295-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25854169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Toxicol. 2016 Jul;31(7):866-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25545733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gynecol Oncol. 2014 Jul;25(3):236-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25045437</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>